Five-Year Follow-Up of Choroidal Metastasis From Lung Adenocarcinoma Harboring Epidermal Growth Factor Receptor (EGFR) Mutation: A Case Report and Literature Review

被引:0
|
作者
Nakashima, Koki [1 ]
Demura, Yoshiki [2 ]
Tada, Toshihiko [2 ]
Ishizuka, Tamotsu [1 ]
机构
[1] Univ Fukui, Dept Resp Med, Fukui, Japan
[2] Japanese Red Cross Fukui Hosp, Dept Resp Med, Fukui, Japan
关键词
bevacizumab; pemetrexed; egfr-tki; epidermal growth factor receptor (egfr); ocular metastasis; choroidal metastasis; lung cancer; CANCER; OSIMERTINIB; THERAPY; VISION;
D O I
10.7759/cureus.66537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This is a long-term follow-up case report of a 71-year-old man with lung adenocarcinoma and choroidal metastasis harboring an epidermal growth factor receptor mutation. Blurry vision, caused by the choroidal metastasis, improved with first-line treatment with afatinib. Thereafter, osimertinib was administered as a second-line treatment, then chemotherapy containing pemetrexed plus bevacizumab as a third-line treatment. For 61 months, recurrence of choroidal metastasis was absent. Only a few reports of lung cancer with choroidal metastasis provide long-term follow-up of more than five years. Therefore, the clinical course of this patient may provide some insights for long-term management in such cases.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma
    Matsumura, Yuki
    Hayasaka, Kazuki
    Ohira, Tetsuya
    Shiono, Satoshi
    Abe, Jiro
    Notsuda, Hirotsugu
    Sakurada, Akira
    Suzuki, Hiroyuki
    Okada, Yoshinori
    INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 2023, 37 (05):
  • [22] Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lung
    Luo, Yung-Hung
    Wu, Chieh-Hung
    Huang, Chu-Yun
    Wu, Chih-Wei
    Wu, Wen-Shuo
    Lee, Yu-Chin
    Whang-Peng, Jacqueline
    Chen, Yuh-Min
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E440 - E448
  • [23] Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis
    Huang, Ruofan
    Ge, Mengxi
    Zhou, Xinli
    Ji, Xiaoyu
    Liao, Li
    Liang, Xiaohua
    Zhan, Qiong
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2019, 34 (02) : 128 - 133
  • [24] Biological Characteristics and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Efficacy of EGFR Mutation and its Subtypes in Lung Adenocarcinoma
    Lu, Rong-li
    Hu, Cheng-Ping
    Yang, Hua-ping
    Li, Yuan-yuan
    Gu, Qi-hua
    Wu, Lielin
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (02) : 445 - 451
  • [25] Surgical resection after gefitinib treatment in patients with lung adenocarcinoma harboring epidermal growth factor receptor gene mutation
    Takamochi, Kazuya
    Suzuki, Kazuya
    Sugimura, Haruhiko
    Funai, Kazuhito
    Mori, Hiroki
    Bashar, Abul Hasan Muhammad
    Kazui, Teruhisa
    LUNG CANCER, 2007, 58 (01) : 149 - 155
  • [26] Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
    Si, Jinfei
    Gu, Xiaodong
    Wang, Wenxian
    Ying, Shenpeng
    Song, Zhengbo
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (05) : 1624 - 1634
  • [27] Combination Therapy With Erlotinib and Ramucirumab in a Patient With Epidermal Growth Factor Receptor Mutation Positive Lung Adenocarcinoma and Interstitial Pneumonia: A Case Report
    Tanaka, Shunya
    Tsuji, Taisuke
    Jinno, Kazuki
    Matsumoto, Shoki
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [28] Putative lung adenocarcinoma with epidermal growth factor receptor mutation presenting as carcinoma of unknown primary site A case report
    Yamasaki, Masahiro
    Funaishi, Kunihiko
    Saito, Naomi
    Sakano, Ayaka
    Fujihara, Megumu
    Daido, Wakako
    Ishiyama, Sayaka
    Deguchi, Naoko
    Taniwaki, Masaya
    Ohashi, Nobuyuki
    Hattori, Noboru
    MEDICINE, 2018, 97 (07)
  • [29] Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation
    Peng, Jianfeng
    Zhao, Xianguang
    Zhao, Kaikai
    Meng, Xiangjiao
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] First-line pemetrexed and carboplatin plus anlotinib for epidermal growth factor receptor wild-type and anaplastic lymphoma kinase-negative lung adenocarcinoma with brain metastasis A case report and review of the literature
    Zhang, Chu
    Kong, Feng-Wei
    Wu, Wen-Bin
    Zhang, Miao
    Yu, Guang-Mao
    Wang, Xiang
    Liu, Yuan-Yuan
    MEDICINE, 2020, 99 (36)